Marian K Kim, MD
Obstetrics/Gynecology · Redwood City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kim’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G73646 · Current
Licensed to practise in California · since 1992 · expires 2027-08-31 · Oregon Health Sciences University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$4,667
Medicare paid this office $4,667 for 55 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 15 | $1,703 | $74 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 33 | $1,574 | $48 |
Who their Medicare patients are
55 Original Medicare patients in 2024. Average age 72 · Women 100% · Health risk score 0.83. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 36%.
The office billed $16,617, Medicare allowed $5,751 and paid $4,667; for 73 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 55 | 73 | 72 | 0.83 | $16,617 | $4,667 |
| 2023 | 39 | 56 | 74 | 0.87 | $13,640 | $4,107 |
| 2022 | 49 | 91 | 74 | 0.79 | $26,027 | $7,033 |
| 2021 | 43 | 70 | 71 | 1.03 | $14,514 | $4,832 |
| 2020 | 28 | 58 | 73 | 1.08 | $13,647 | $4,030 |
| 2019 | 44 | 75 | 72 | 1.01 | $21,726 | $5,309 |
| 2018 | 34 | 45 | 71 | 0.68 | $7,905 | $2,253 |
| 2017 | 28 | 46 | 72 | 1.02 | $12,688 | $3,408 |
| 2016 | 35 | 61 | 70 | 0.66 | $15,186 | $4,057 |
| 2015 | 44 | 71 | 71 | 0.84 | $15,808 | $4,288 |
| 2014 | 50 | 77 | 70 | 0.64 | $19,044 | $5,106 |
| 2013 | 47 | 89 | 71 | 0.85 | $27,579 | $6,514 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Short return visit (20+ min) | 17 | $1,900 | $83 |
2022: 2 services
| Short return visit (20+ min) | 22 | $2,936 | $84 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 18 | $850 | $47 |
2021: 2 services
| Short return visit (20+ min) | 11 | $1,228 | $88 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 18 | $857 | $48 |
2020: 2 services
| Short return visit (20+ min) | 14 | $1,320 | $66 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 16 | $766 | $48 |
2019: 2 services
| Short return visit (20+ min) | 12 | $1,064 | $63 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 17 | $795 | $47 |
2018: 1 service
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 22 | $988 | $45 |
2017: 1 service
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 15 | $687 | $46 |
2016: 1 service
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 17 | $777 | $46 |
2015: 2 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 21 | $1,008 | $48 |
| Short return visit | 14 | $573 | $36 |
2014: 2 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 24 | $1,086 | $45 |
| Short return visit | 11 | $393 | $33 |
2013: 2 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 24 | $1,095 | $46 |
| Short return visit | 12 | $568 | $38 |
Drugs they prescribed that Part D paid
$12,124
Pharmacies billed $12,124 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 150) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
133 generic and 17 brand-name prescriptions · $12,124 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol (Twice Weekly) | 11 | $1,888 | $172 |
| Estradiol | 27 | $1,087 | $40 |
| Progesterone | 16 | $803 | $50 |
| Fluconazole | 19 | $211 | $11 |
Year by year
| 2024 | 150 | 40 | 0% (0) | 11% | $12,124 |
| 2023 | 146 | 37 | None | 16% | $21,331 |
| 2022 | 124 | 33 | 0% (0) | 30% | $21,913 |
| 2021 | 77 | 27 | 0% (0) | 29% | $9,943 |
| 2020 | 99 | 22 | 0% (0) | 19% | $11,694 |
| 2019 | 72 | 25 | 0% (0) | 26% | $9,588 |
| 2018 | 82 | 19 | 0% (0) | 39% | $8,896 |
| 2017 | 67 | 19 | 0% (0) | 34% | $8,534 |
| 2016 | 78 | 26 | 0% (0) | 33% | $8,718 |
| 2015 | 77 | 24 | None | 56% | $11,864 |
| 2014 | 89 | 28 | None | 38% | $9,099 |
| 2013 | 67 | 22 | None | 36% | $7,890 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Premarin | 13 | $6,666 | $513 |
| Estradiol | 28 | $2,216 | $79 |
| Yuvafem | 11 | $2,182 | $198 |
| Progesterone | 22 | $1,672 | $76 |
| Fluconazole | 17 | $110 | $6 |
2022: 3 drugs
| Premarin | 19 | $9,243 | $486 |
| Estradiol | 20 | $1,663 | $83 |
| Oxybutynin Chloride Er | 11 | $453 | $41 |
2021: 3 drugs
| Estradiol (Twice Weekly) | 11 | $1,322 | $120 |
| Estradiol | 16 | $1,202 | $75 |
| Fluconazole | 11 | $76 | $7 |
2020: 3 drugs
| Estradiol (Twice Weekly) | 16 | $2,844 | $178 |
| Progesterone | 31 | $1,518 | $49 |
| Estradiol | 19 | $1,059 | $56 |
2019: 2 drugs
| Estradiol | 21 | $3,018 | $144 |
| Progesterone | 13 | $985 | $76 |
2018: 1 drug
| Estradiol | 36 | $3,549 | $99 |
2017: 1 drug
| Estradiol | 27 | $2,705 | $100 |
2016: 2 drugs
| Estradiol | 31 | $1,638 | $53 |
| Progesterone | 12 | $674 | $56 |
2015: 4 drugs
| Premarin | 17 | $4,251 | $250 |
| Clobetasol Propionate | 12 | $1,710 | $142 |
| Progesterone | 12 | $486 | $40 |
| Estradiol | 15 | $440 | $29 |
2014: 2 drugs
| Premarin | 11 | $2,246 | $204 |
| Estradiol | 12 | $92 | $8 |
2013: 1 drug
| Estradiol | 16 | $563 | $35 |
Professional record
- NPI
- 1447327861
- Licence
- CA G73646California G73646: Current · expires 2027-08-31
- Trained
- Oregon Health Sciences University School of Medicine, 1990
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-11-29
- NPI last updated
- 2020-05-14
- NPI record certified
- 2020-05-14
This is when the NPI record was last certified, not a medical board exam.